Myriad Group First Quarter 2010 Results Sofinnova

Myriad Group First Quarter 2010 Results

Publiée le 20/05/2010

DUEBENDORF-ZURICH, Switzerland – 20 May 2010 – Myriad Group AG (SIX: MYRN), a global leader in mobile technology with software in over 2 billion phones, announced further details of its Q1 2010 results today.
Revenue for Q1 2010 amounted to USD 28.5 million compared to Q1 2009 pro forma1 revenue of USD 32.2 million.

Visiter le site internet www.myriadgroup.com Télécharger le fichier 1048_fichier_attache.pdf

2010

04/01/2010
Inside Contactless and Taztag Partner on NFC Innovations
05/01/2010
Endotis Pharma invited to present at the 28th Annual JP Morgan Healthcare Conference in San Francisco
05/01/2010
Endotis Pharma est invitée à présenter à la 28ème Conférence Annuelle « JP Morgan Healthcare » à San Francisco
14/01/2010
Preglem presenting at JP morgan Healthcare conference on 14th january 2010
14/01/2010
Sagem Wireless to deliver connected mobile experience for brand partners
20/01/2010
Bioamber Commissions World’s First Renewable Succinic Acid Plant
22/01/2010
Blyk invited to present at TM Forum, Singapore 27-28 January 2010
26/01/2010
Major smart card market players join forces to advance open and secure public transport smart card applications
26/01/2010
Sofinnova Partners annonce la clôture de son sixième fonds à hauteur de 260 millions d’euros
26/01/2010
Sofinnova Partners Announces Closing of Sixth Fund for €260 million
27/01/2010
Movetis launches Resolor® in Germany
27/01/2010
Sofinnova Partners Completes Exit to Tyco Electronics Ltd
19/01/2010
Sofinnova Partners Invests €2.3 million in Prestige Mobile Innovator - Celsius X VI II
25/01/2010
Varioptic Announces Optical Image Stabilization for Mobile Phones
04/01/2010
Varioptic Signs License Deal with Cognex
02/02/2010
UPEK Extends Fingerprint Solution Leadership With Over 70 Million Hardware and Software Products Deployed, UPEKLeads the Industry in Delivering Fingerprint-Based Identity ManagementSolutions for Consumers and Businesses
02/02/2010
PC30 : chiffre d’affaires 2009 en forte croissance
01/02/2010
Capgemini Consulting and blueKiwi to work together to help organizations build the 2.0 enterprise
04/02/2010
7TM Pharma successfully conducts clinical phase I trial with its second generation CB1 receptor antagonist
04/02/2010
DNP Green Technology Acquires Sinoven Biopolymers
08/02/2010
Myriad brings 3x Faster Applications, Richer Game Graphics And Better Battery Life To Android
11/02/2010
Ablynx wins patent opposition case against Domantis (GSK)
15/02/2010
Streamezzo Announces a New release of its Mobile Application Development Platform; This release is designed to dramatically reduce development life cycle of cross-platform applications without limiting developer's creativity
15/02/2010
INSIDE Achieves First Commercial Deployment of Its NFC Technologies
15/02/2010
Sagem Wireless dévoile le cosyphone - Un objet communiquant très simple d'utilisation pour le marché des séniors
15/02/2010
Stentys drug-eluting self-expanding coronary stent shows 4% restenosis in complex lesions
15/02/2010
Myriad Group Announces Strong Growth in Fiscal Year 2009
16/02/2010
Telefonica Mexico and Myriad Group Named As Finalist for GSMA Global Mobile Award
17/02/2010
Sofinnova Partners invests in OpenERP
17/02/2010
Sofinnova Partners entre au capital d’OpenERP
23/02/2010
GlycoVaxyn’s First Clinical Study with Bioconjugate Vaccine Initiated
25/02/2010
Ablynx announces 2009 full year results
25/02/2010
Ablynx plans a secondary public offering on Euronext Brussels
01/03/2010
Sofinnova is the european venture capital firm of the year
01/03/2010
Sofinnova obtient le prix du Fonds Venture
04/03/2010
Sagem Wireless Partners with ST-ERICSSON
08/03/2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova™, a Prescription Omega 3 Therapy
05/03/2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
11/03/2010
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
15/03/2010
Ablynx sucessfullly raises €50 million with secondary public offering final price: €7.5 per share
15/03/2010
PC30 démarre l’installation des nouveaux compteurs d’électricité LINKY sous la marque ENERGY 30
22/03/2010
Neosens a reçu le 1er prix des Trophées de l’Innovation dans la catégorie ‘Equipements & Procédés’ pour sa solution de surveillance en continu et en ligne des encrassements dans le secteur de l’agroalimentaire.
19/03/2010
Myriad's New J2Android Converter Fuels Android Applications Gold Rush
24/03/2010
Movetis announces that Resolor® is now available in the UK
25/03/2010
DNP Green Technology and GreenField Ethanol are Partnering to build a Biobased Succinic Acid De-icer Plant
26/03/2010
Ablynx selects a novel pre-clinical development candidate for administration via pulmonary delivery
29/03/2010
Omthera Pharmaceuticals, Inc. Names George Horner as Chairman of the Board Pharmaceutical Industry Veteran Joins Omthera in Effort to Advance Dyslipidemia Therapy
30/03/2010
Inside powers first contactless public transit payments in latin america
16/03/2010
Topscomm Selects Accent for China Smart Grid Powerline Communication Applications
08/04/2010
Comptes 2009 : PC30 dépasse ses objectifs de croissance
12/04/2010
John Searle Joins ReVolt Technology as Non-Executive Chairman
06/04/2010
Sofinnova Partners : Laureat 2010 Capital Finance pour la meilleure équipe
10/04/2010
PC30 devient SOLUTIONS 30
14/04/2010
Accent Expands its Wireless Communication Capabilities with the Opening of a new IP Development Center in Sophia Antipolis, France
14/04/2010
Inside Contactless to exhibit at cards Asia 2010
17/04/2010
Endotis Pharma EP80061 small-glyco drug to be presented at the AACR meeting in Washington DC, April 17th to 21st, 2010
22/04/2010
Inside Contactless, Sagem Orga and Taztag Partner on new NFC mobile payment device
26/04/2010
Telefonica selects Myriad Group to provide mobile social networking services across latin america
16/04/2010
Mentum Acquires Ascom’s Network Planning Business Unit Creating Global Leader in Network Planning
15/04/2010
Mobile Industry Veteran Mitch Lazar Joins Taptu As Non-Executive Director
03/05/2010
Wade Guindy Joins ReVolt Technology LLC as COO and EVP of Technology Industry Veteran to Head Global Operations for ReVolt Technology Group
03/05/2010
NOXXON Announces the Completion of the First-in-Human Clinical Trial with Spiegelmer NOX-A12
04/05/2010
Inside Contactless proposes to buy Atmel's secure microcontroller solutions business
04/05/2010
GlycoVaxyn and a Harvard University affiliated hospital receive USD 3.4 million NIH grant for Staphylococcus aureus vaccine development Program to leverage GlycoVaxyn Proprietary in vivo conjugation technology
05/05/2010
ReVolt Technology LLC Selected for $5 Million ARPA-E BEEST Grant Award
05/05/2010
Blyk launches its Youth Brand in the Netherlands
18/05/2010
Preglem announces positive phase III results for ESMYATM as an effective treatment for uterine fibroids
18/05/2010
NOXXON Pharma AG appoints Dr. Aram Mangasarian as Chief Business Officer
18/05/2010
Cerenis Reports Positive Results for Phase 1 Study of CER-001, an HDL mimetic, for the Treatment of Cardiovascular Disease
19/05/2010
Inside Contacteless and CPI card group receive discover certification for mobile payment sticker
20/05/2010
Myriad Group First Quarter 2010 Results
25/05/2010
Sofinnova Partners annonce la cession de Sprice à Travelport
25/05/2010
Sofinnova Partners portfolio Company Sprice Sold to Travelport
01/06/2010
Industry leaders debut next-generation mastercard-approved mobile payment sticker
02/06/2010
MicroPass 4002-Based Discover Zip Sticker Available Now from CPI
28/05/2010
Myriad Group Announces Addition to its Executive Team
03/06/2010
Preglem announces positive phase III results for ESMYATM
03/06/2010
Preglem annonce des résultats positifs pour les études de Phase III d'ESMYA(TM)
03/06/2010
Endotis Pharma presents data on the neutralizable anticoagulant EP217609 in an extracorporeal circulation model.
01/06/2010
Myriad Group and MIPS Technologies Accelerate Android™ Application Performance up to 5x
27/05/2010
NOXXON Pharma AG raises €33 million in Series D Round
08/06/2010
IBM Global Entrepreneur : l’événement le 24 /09/2010
12/06/2010
Solutions30 : " nous tablons sur une croissance à deux chiffres"
01/07/2010
Sofinnova Partners, Gimv and Amundi Private Equity Funds invest in McPhy Energy
28/06/2010
NOXXON Pharma AG announces management changes
06/07/2010
DBV Technologies receives IND clearance from FDA to begin clinical trial in peanut allergy
07/07/2010
Noxxon to initiate phase Ib clinical trial of MCP-1 inhibitor NOX-E36
13/07/2010
HID global and Inside Contactless turn NFC Mobile phones into secure ID and access device
08/07/2010
Bioamber and DuPont Applied BioSciences Announce Licensing Agreement on Derivatives of Biobased Succinic Acid
26/07/2010
Cerenis Therapeutics raises 40 million in Series C financing
20/07/2010
Emailvision now world’s fastest growing Email Service Provider
29/07/2010
Solutions30 | Chiffre d’affaires du 1er semestre 2010 : croissance soutenue
29/07/2010
Solutions30 | Turnover for the 1st half of 2010: steady growth
03/08/2010
Movetis receives a tender offer from Shire of €19 cash per share for all outstanding shares and warrants
30/07/2010
Sofinnova Partners completes the sale of its participation in Emailvision to Francisco Partners
25/08/2010
Addex Partner Completes ADX71149 Phase I Program
30/07/2010
Sofinnova Partners annonce la cession de sa participation dans Emailvision à Francisco Partners
29/07/2010
Inside's ICAO-Lite platform open doors for TIL Technologies
05/08/2010
Last.fm partners with MXP4 to make music ads sticky
11/08/2010
Preglem announces in-licensing deal with Merck Serono for post-operative adhesions & endometriosis
11/08/2010
Preglem annonce un contrat de licence avec Merck Serono sur les adhérences post-opératoires et l'endométriose
24/08/2010
Le PDG de BlueKiwi s’installe aux Etats-Unis
27/08/2010
ReVolt Technology LLC Announces Successful Completion of Negotiations of $5 Million ARPA-E BEEST Award and Approval of $6.8 million in Loans and Tax Credits from the State of Oregon and City of Portland
08/09/2010
Addex Awarded Michael J. Fox Foundation Grant for ADX48621 to treat Levodopa-Induced Dyskinesia in Parkinson's Disease
02/09/2010
Devrait-on encourager les grands groupes français à racheter comme Google & Cie ?
07/09/2010
AuthenTec and UPEK Announce Merger
15/09/2010
Addex Pharmaceuticals Raises CHF20 Million from Biotechnology Value Fund
16/09/2010
Ascendis Pharma initiates Phase 2 clinical study of ACP-001, a once-weekly human growth hormone product
23/10/2010
ReCor reports successful first-in-human clinical case using ultrasound to cure mitral regurgitation (MR)
22/09/2010
Stentys self-apposing stent proves superior to conventional treatment of Acute Myocardial Infarction
28/09/2010
Inside Contactless first to be certified for star certiflash
30/09/2010
Ablynx inititates Phase II clinical trial for TTP
01/10/2010
Ablynx receives further milestone payments of €3 million as part of its strategic alliance with BoehringerIngelheim
01/10/2010
Inside Contactless completes purchase of Atmel's secure microcontroller solutions business
29/09/2010
Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer
06/10/2010
Twenga - Nominations
07/10/2010
Sofinnova Partners annonce la cession de Preglem à Gedeon Richter pour une valeur totale de CHF445m ( €337m)
08/10/2010
GlycoVaxyn Phase I Clinical Study Shows Positive Data with Shigella dysenteriae Vaccine Candidate
07/10/2010
Sofinnova Partners announces the sale of Preglem to Gedeon Richter for a total value of CHF445m ( €337m)
11/10/2010
Ablynx and Merck Serono enter into second agreement to co-discover and co-develop NANOBODIES®
20/10/2010
Taptu switches executives around as the US beckons
20/10/2010
Taptu Appoints Former Yahoo! Mobile Europe Head Mitch Lazar as New CEO Lazar Evolving Company Beyond Mobile Search
19/10/2010
OpenERP Solves Open Source's Vexing Problem: Making Money Back to Online Version
22/10/2010
Sofinnova Partners annonce que Stentys, une société de son portefeuille, lève 22,7M€ hors exercice de l'option de sur-allocation
22/10/2010
Sofinnova Partners' portfolio company Stentys sucessfully raises €22.7M, subject to the exercise of the over-allotment option
28/10/2010
Parcours d'entrepreneur : Bastien Duclaux - Twenga
28/10/2010
SOLUTIONS 30: Q3 2010 sales
28/10/2010
SOLUTIONS 30 : Chiffre d’affaires du 3ème trimestre 2010
08/11/2010
Omthera Pharmaceuticals, Inc. Announces Initiation of the ECLIPSE Trial: Epanova Compared to Lovaza In a Pharmacokinetic Single-dose Evaluation
15/11/2010
Endotis Pharma reports successful completion of the neutralization study of the anticoagulant EP217609 by avidin in healthy subjects
23/11/2010
Qosmos, N¢X 39 des entreprises technologiques de croissance du classement Technology Fast 50 ¡V 2010 de Deloitte
22/11/2010
Developer Workshop: Taptu
29/11/2010
Combines NFC Controller, Secure Element, Java Card OS and Open NFC Stack to Ease Mobile Handset Integration
30/11/2010
Inside Contactless passes 250 Million unit milestone for micropass shipments
06/12/2010
New Name Highlights Focus on Secure Semiconductor Platforms
07/12/2010
Open NFC Open Source Software Honored by Prestigious Panel of Experts
17/12/2010
My Taptu review / Review Verdict
20/12/2010
Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery Technology in Diabetes and Related Disorders
20/12/2010
Sanofi-aventis acquiert auprès d’Ascendis Pharma une licence mondiale sur une technologie de libération de médicaments dans le diabète et ses troubles associés
20/12/2010
Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery Technology in Diabetes and Related Disorders
20/12/2010
Sanofi-aventis acquiert auprès d’Ascendis Pharma une licence mondiale sur une technologie de libération de médicaments dans le diabète et ses troubles associés

Découvrez le site Sofinnova Ventures, notre société soeur à San Francisco http://www.sofinnova.com

Actualités

Myriad Group First Quarter 2010 Results

2010

Sofinnova